Home
Our Company

Our Company Market Share Analysis for March 2026

CSL Seqirus is a global influenza vaccine company developing innovative solutions to ensure epidemic and pandemic preparedness throughout the world.

Industry: N/A

Domaincslseqirus.us

Year Founded--

Employees51 - 200

Annual Revenue--

Our Company

Our Company (including company regionals)

cslseqirus.us

See more website traffic and engagement information

Total visits to Our Company's top domains

Understand Our Company market share and potential market reach.

Total visits last 3 months

Subsidiaries Breakdown

cslseqirus.us7.3K

See more with Sales Intelligence

Avg. visit duration in Our Company's top domains

Analyze Our Company engagement metrics.

Average visit duration last 3 months

Subsidiaries Breakdown

cslseqirus.us00:00:25

See more with Sales Intelligence

Avg. pageviews on Our Company's top domains

See how Our Company keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

Subsidiaries Breakdown

cslseqirus.us1.46

See more with Sales Intelligence

Our Company top competitors by domain

Top similar sites in March 2026, ranked by their affinity

merckvaccines.comCompany NameMerck VaccinesEmployees51 - 200HQUnited States, Pennsylvania, West PointAnnual revenue$25M - $50MTotal visits34.4KHealth > Pharmacy

Top technologies used by Our Company

These are the website technologies, by industry, used by Our Company top domains

Audio Video Media (2)

VideoJS

Social (2)

Instagram

Advertising (1)

DoubleClick

Content Management System (1)

Sitecore CMS

More Technologies

4

See all

News & Signals from Our Company

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

NewsCSL Seqirus Inc. invests into assets: manufacturing facility in the amount of $140M in Holly Springs, North Carolina, United States, Northern America, Americas.Seqirus, a global leader in influenza prevention, will invest $140M in an expansion of its Holly Springs, NC manufacturing facility.

NewsValneva SE partnered with CSL Seqirus Inc. on Jun 25th '25.Saint-Herblain, France, June 26, 2025 - Valneva SE, (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced an exclusive agreement with CSL Seqirus, one of the world's largest influenza vaccine companies, for the marketing and distribution of Valneva's three proprietary vaccines in Germany.